Email

Acid Antagonists, Folic

Inhibitors of the enzyme, Dihydrofolate Reductase (Tetrahydrofolate Dehydrogenase), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer Chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)